International Eosinophil Society Inc
- Assets
- $691.2k
- Revenue
- $534.8k
- Investments
- $0.0
- Employees
- 0
- Location
- Milwaukee, WI
- Founding
- 08/2011
- Data as of
- 12/2023
- EIN
- 27-2696878
Organization Overview
International Eosinophil Society Inc is located in Milwaukee, WI. The organization was established in 2011. According to its NTEE Classification (G43) the organization is classified as: Heart & Circulatory System Diseases & Disorders, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. International Eosinophil Society Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, International Eosinophil Society Inc generated $534.8k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 8.6% each year. All expenses for the organization totaled $293.4k during the year ending 12/2023. While expenses have increased by 4.6% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE INTERNATIONAL EOSINOPHIL SOCIETY, INC. IS AN ORGANIZATION OF SCIENTISTS AND CLINICIANS INTERESTED IN THE EOSINOPHIL, A BLOOD CELL STRONGLY ASSOCIATED WITH MANY DISEASES. THE SOCIETY SPONSORS BIENNIAL MEETINGS TO REVIEW NEW INFORMATION ABOUT THE EOSINOPHIL AND ITS ROLES IN HEALTH AND DISEASE. THE INTERNATIONAL EOSINOPHIL SOCIETY, INC. (IES, INC.) HAS BEEN ESTABLISHED TO BRING TOGETHER SCIENTISTS AROUND THE WORLD WHO ARE ENGAGED IN RESEARCH IN THE FIELD OF EOSINOPHIL BIOLOGY AND EOSINOPHIL DISORDERS WITH A VIEW TO FACILITATING EXCHANGE OF IDEAS AND INFORMATION ABOUT THIS FASCINATING INFLAMMATORY CELL TYPE AND ITS ROLE IN DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE 2023 SYMPOSIUM SHOWCASES NEW RESEARCH FINDINGS RELATED TO THE PRODUCTION OF EOSINOPHILS, THEIR TRAFFICKING, THEIR EFFECTOR FUNCTIONS, THE USE OF ANIMAL MODELS TO EXPLORE THE IMPORTANCE AND ROLE OF THE EOSINOPHIL IN HEALTH AND DISEASE, TRANSLATIONAL STUDIES OF ANIMAL MODEL FINDINGS INTO PATIENT-ORIENTED RESEARCH, AND THE DEVELOPMENT OF NEW THERAPIES OF EOSINOPHIL-ASSOCIATED DISEASES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Florence Roufosee MD PHD Past President | OfficerTrustee | 2 | $0 |
Marc Rothenberg MD PHD President | OfficerTrustee | 2 | $0 |
Dagmar Simon MD Past Secretary-Treasurer | OfficerTrustee | 2 | $0 |
Bruce Bochner MD Past President | OfficerTrustee | 2 | $0 |
Allison D Fryer PHD President-Elect | OfficerTrustee | 2 | $0 |
Praveen Akuthota MD Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $398,108 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $398,108 |
| Total Program Service Revenue | $113,688 |
| Investment income | $10,432 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $12,549 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $534,777 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $26,709 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $80,000 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $1,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $25 |
| Advertising and promotion | $809 |
| Office expenses | $10,437 |
| Information technology | $3,290 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $25,716 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $143,417 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $2,020 |
| All other expenses | $0 |
| Total functional expenses | $293,423 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $190,898 |
| Savings and temporary cash investments | $500,029 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $250 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $691,177 |
| Accounts payable and accrued expenses | $323 |
| Grants payable | $0 |
| Deferred revenue | $10,513 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $10,836 |
| Net assets without donor restrictions | $651,265 |
| Net assets with donor restrictions | $29,076 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $691,177 |